Video Latest - ecancer

Advances for NSCLC in review

Dr Stefan Zimmermann - Hôpital Fribourgeois, Fribourg, Switzerland

9 Oct 2016

Ceritinib following crizotinib relapse for ALK positive NSCLC

Dr Giorgio Scagliotti - University of Turin, Turin, Italy

9 Oct 2016

Fulvestrant in FALCON trial improves PFS in advanced breast cancer

Dr Matthew Ellis - Washington University in St Louis, USA

8 Oct 2016

Dabrafenib shows higher response and lower toxicity in paediatric brain cancer trial

Dr Mark Kieran - Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, USA

8 Oct 2016

Ipilimumab as adjuvant therapy improves OS in high risk melanoma

Prof Alexander Eggermont - Institut Gustave Roussy, Villejuif, France

8 Oct 2016

Ribociclib improves PFS for postmenopausal women with hormone receptor-positive breast cancer

Dr Gabriel Hortobagyi - MD Anderson, Houston, USA

8 Oct 2016

Editor's Choice for September 2016

Prof Gordon McVie - Editor in Chief, ecancer

3 Oct 2016

What is the role of surgery in melanoma treatment?

Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy

26 Sep 2016

The role of chemotherapy for metastatic melanoma

Prof Paul Lorigan - University of Manchester, Manchester, UK

26 Sep 2016

Checkpoint inhibitor therapy for treating melanoma

Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA

22 Sep 2016

Developing new models in SCLC

Prof Caroline Dive - Cancer Research UK Manchester Institute, Manchester, UK

14 Sep 2016

Nitroglycerin in cancer treatment

Dr Pan Pantziarka - Anticancer Fund, UK

14 Sep 2016

Video